Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa
Clinical trial NCT01670500 · COMPLETED
Trial details
- NCT number
- NCT01670500
- Sponsor
- Beth Israel Deaconess Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2019-05-01
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.